CUE: Lin Shao-Lee sold $305K of stock
By AlphaYouPublished Form 4
Lin Shao-Lee
Reporting filer
Lin Shao-Lee reported selling 11,087 shares of Cue Biopharma, Inc. for about $305K ($27.55 a share on average). Form 4 filed Oct 15, 2026 lists 2 entries.
See the price move since this trade →
- Disclosed
- Oct 15, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Lin Shao-Lee | 2026-10-12 | S | Sale | 10000 | 27.50 | 695,995 | 3 days | Filed terms
|
| Common Stock | Lin Shao-Lee | 2026-10-12 | S | Sale | 1087 | 28.05 | 694,908 | 3 days | Filed terms
|
Common Stock
- Owner
- Lin Shao-Lee
- Date
- 2026-10-12
- Code
- S
- Action
- Sale
- Quantity
- 10000
- Price
- 27.50
- Following holdings
- 695,995
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-12
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 10000
- transaction Price Per Share: 27.50
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 695995
- direct Or Indirect Ownership: D
- nature Of Ownership:
Common Stock
- Owner
- Lin Shao-Lee
- Date
- 2026-10-12
- Code
- S
- Action
- Sale
- Quantity
- 1087
- Price
- 28.05
- Following holdings
- 694,908
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-12
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 1087
- transaction Price Per Share: 28.05
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 694908
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Lin Shao-Lee: Chief Executive Officer, Director.
- F1: The sales reported represent shares sold pursuant to the Issuer's Company-Wide Policy and do not represent discretionary transactions by the Reporting Person. These sales were made automatically to satisfy mandatory tax withholding obligations through a "sell-to-cover" transaction in connection with the vesting and settlement of restricted stock units, and the Reporting Person did not exercise any control over the timing, price or number of shares sold.
Original sources
Prepared automatically from public filing data. Report a correction.